Condensed Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current Assets
Cash	$ 8,641	$ 152,487
Prepaid expenses	47,958	253,120
Dividend receivable	426,433
Total Current Assets	483,032	405,607
Investments held in Trust Account	230,682,837	230,092,305
TOTAL ASSETS	231,165,869	230,497,912
Current Liabilities
Accrued expenses	499,494	655,716
Working Capital Loan from Sponsor	375,000
Total Current Liabilities	874,494	655,716
Warrant liability	68,000	2,856,000
Deferred underwriting fee payable	8,050,000	8,050,000
Total Liabilities	8,992,494	11,561,716
Commitments and Contingencies
Common stock subject to possible redemption, $0.0001 par value: 23,000,000 and 23,000,000 shares issued and outstanding at $10.00 per share at redemption value at September 30, 2022 and December 31, 2021, respectively	230,000,000	230,000,000
Stockholders’ Equity (Deficit)
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,750,000 and 5,750,000 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	575	575
Additional paid-in capital
Accumulated deficit	(7,827,200)	(11,064,379)
Total Stockholders’ Equity (Deficit)	(7,826,625)	(11,063,804)
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 231,165,869	$ 230,497,912